With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

Tom Brady, renowned for his illustrious NFL career, is now making headlines in the realm of biotechnology. As an investor and cultural advisor for Colossal Biosciences, Brady is ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

The glove box market is propelled by increasing demand across industries such as pharmaceuticals, healthcare, semiconductors, and nuclear research, where controlled environments are essential. Rising ...

Iovance has a huge opportunity with its tumor-infiltrating lymphocyte (TIL) therapies. However, there are several drawbacks to investing in the stock right now. Even if Iovance isn't a ...

Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron, its ...

With biotech firms caught in the crosshairs of Trump’s tariffs, the levy could prove to be a boon for domestic producers but a bane for exporters.

The sector is defensive, and biopharmaceuticals have, for the most part, limited tariff and transfer price exposure, he ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Amid a massive reorganization of the federal healthcare infrastructure that has prompted pushback from biotech and healthcare ...

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...